Titan Laboratories (P) Ltd. Revenue and Competitors
Estimated Revenue & Valuation
- Titan Laboratories (P) Ltd.'s estimated annual revenue is currently $1.7M per year.
- Titan Laboratories (P) Ltd.'s estimated revenue per employee is $36,957
Employee Data
- Titan Laboratories (P) Ltd. has 46 Employees.
- Titan Laboratories (P) Ltd. grew their employee count by 10% last year.
Titan Laboratories (P) Ltd.'s People
| Name | Title | Email/Phone |
|---|
What Is Titan Laboratories (P) Ltd.?
Titan Laboratories (P) Ltd. is one of the few companies in India with dedicated state of art WHO GMP manufacturing facilities for producing high quality Sustained and Modified Release Pellets, DC Granules & Taste Masked Granules, Solid Dosage Finished Formulations (Tablets and Capsules) We are one of the few Indian Finished Formulation manufacturing company having more than 11 International Accreditation for complete plant with All Sections. Our commitment to unflinching quality assurance has received endorsements from various International Health/ Quality Authorities like: 1) EU-GMP 2) TGA – AUSTRALIA 3) INVIMA – COLOMBIA 4) DIGEMED - PERU 5) MFDS - KOREA 6) DACA - ETHIOPIA 7) GMP - PHILIPPINES 8) PPB - KENYA 9) GMP - UKARAINE 10) WHO-GMP
keywords:N/A
N/A
Total Funding
46
Number of Employees
$1.7M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Titan Laboratories (P) Ltd. News
By end user (diagnostic labs, hospitals and clinics, research and academic ... Quidel Corporation, Titan Biotech Ltd HiMedia Laboratories,...
We wish to extend the opportunity to the larger Titan Community (students, ... The EEI participants will take part in lab experiments,...
The Tracer Pack: Kong Limited Time Bundle celebrates a Titan with nearly 90 ... weapon has certainly come out of a high-tech weapons lab.
Other Companies in Mumbai
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.2M | 46 | 5% | N/A |
#2 | $3.7M | 46 | 15% | N/A |
#3 | $3.8M | 46 | 10% | N/A |
#4 | $2.7M | 46 | 15% | N/A |
#5 | $2.8M | 46 | -18% | N/A |